Join the Global Community Advancing Esophageal Disease Understanding in Brisbane – September 2025

ISDE ISDE World Congress brings together professionals focused on esophageal diseases like cancer, eosinophilic esophagitis, Barrett’s esophagus, and reflux. The program has previously attracted over 800 delegates worldwide, promoting connections and knowledge sharing. With over 20 years of experience, attendees gain insights and friendships that benefit their careers. The upcoming event in Brisbane offers a chance to engage with leading experts in the field.

21st ISDE World Congress will be held from September 18-20, 2025 at the Brisbane Convention Center, Australia.

Learn more at https://isde-congress.net/


You may also like

What's New in Chicago Classification 4 - Rena Yadlapati
11views
0likes
The Chicago Classification categorizes esophageal motility disorders in high-resolution manometry tests depicted with color pressure topography plots. Applying standardized HRM metrics to categorize esophageal motility disorders such as ...
Long Term PPI Therapy: Controversies in GERD Part 1 with Kerry Dunbar
6views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
Endoscopic Management of GERD: Controversies in GERD Part 2 with Haruhiro Inoue
8views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
When to consider surgery: Controversies in GERD Part 3 with John Lipham
8views
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact on the patient’s quality of life. The typical symptoms are ...
Page 6 of 6

Comments are closed.